|
1
|
Ali Z, Yousaf N and Larkin J: Melanoma
epidemiology, biology and prognosis. EJC Suppl. 11:81–91.
2013.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Robert C, Long GV, Brady B, Dutriaux C,
Maio M, Mortier L, Hassel JC, Rutkowski P, McNeil C,
Kalinka-Warzocha E, et al: Nivolumab in previously untreated
melanoma without BRAF mutation. N Engl J Med. 372:320–330.
2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Abildgaard C and Guldberg P: Molecular
drivers of cellular metabolic reprogramming in melanoma. Trends Mol
Med. 21:164–171. 2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Fang Y and Fullwood MJ: Roles, functions,
and mechanisms of long non-coding RNAs in cancer. Genomics
Proteomics Bioinformatics. 14:42–54. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Li X, Wu Z, Fu X and Han W: lncRNAs:
Insights into their function and mechanics in underlying disorders.
Mutat Res Rev Mutat Res. 762:1–21. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Yu X, Zheng H, Tse G, Zhang L and Wu WKK:
CASC2: An emerging tumour-suppressing long noncoding RNA in human
cancers and melanoma. Cell Prolif. 51(e12506)2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lu CW, Zhou DD, Xie T, Hao JL, Pant OP, Lu
CB and Liu XF: HOXA11 antisense long noncoding RNA (HOXA11-AS): A
promising lncRNA in human cancers. Cancer Med. 7:3792–3799.
2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Liang L, Zhang Z, Qin X, Gao Y, Zhao P,
Liu J and Zeng W: Long noncoding RNA ZFAS1 promotes tumorigenesis
through regulation of miR-150-5p/RAB9A in melanoma. Melanoma Res.
29:569–581. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Shi G, Li H, Gao F and Tan Q: lncRNA H19
predicts poor prognosis in patients with melanoma and regulates
cell growth, invasion, migration and epithelial-mesenchymal
transition in melanoma cells. Onco Targets Ther. 11:3583–3595.
2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ghaforui-Fard S, Vafaee R and Taheri M:
Taurine-upregulated gene 1: A functional long noncoding RNA in
tumorigenesis. J Cell Physiol. 234:17100–17112. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Di Leva G, Garofalo M and Croce CM:
MicroRNAs in cancer. Annu Rev Pathol. 9:287–314. 2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev Cell. 11:441–450. 2006.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Jiang R, Zhao C, Gao B, Xu J, Song W and
Shi P: Mixomics analysis of breast cancer: Long non-coding RNA
linc01561 acts as ceRNA involved in the progression of breast
cancer. Int J Biochem Cell Biol. 102:1–9. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Zhang H, Jiang M, Liu Q, Han Z, Zhao Y and
Ji S: miR-145-5p inhibits the proliferation and migration of
bladder cancer cells by targeting TAGLN2. Oncol Lett. 16:6355–6360.
2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Jin C, Wang A, Liu L, Wang G, Li G and Han
Z: miR-145-5p inhibits tumor occurrence and metastasis through the
NF-κB signaling pathway by targeting TLR4 in malignant melanoma. J
Cell Biochem. 120:11115–11126. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Grimm D, Bauer J, Wise P, Kruger M,
Simonsen U, Wehland M, Infanger M and Corydon TJ: The role of SOX
family members in solid tumours and metastasis. Semin Cancer Biol.
67:122–153. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Andreucci E, Pietrobono S, Peppicelli S,
Ruzzolini J, Bianchini F, Biagioni A, Stecca B and Calorini L: SOX2
as a novel contributor of oxidative metabolism in melanoma cells.
Cell Commun Signal. 16(87)2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Schaefer SM, Segalada C, Cheng PF, Bonalli
M, Parfejevs V, Levesque MP, Dummer R, Nicolis SK and Sommer L:
Sox2 is dispensable for primary melanoma and metastasis formation.
Oncogene. 36:4516–4524. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wang SH, Zhang WJ, Wu XC, Weng MZ, Zhang
MD, Cai Q, Zhou D, Wang JD and Quan ZW: The lncRNA MALAT1 functions
as a competing endogenous RNA to regulate MCL-1 expression by
sponging miR-363-3p in gallbladder cancer. J Cell Mol Med.
20:2299–2308. 2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Aldred AJ, Cha MC and Meckling-Gill KA:
Determination of a humane endpoint in the L1210 model of murine
leukemia. Contemp Top Lab Anim Sci. 41:24–27. 2002.PubMed/NCBI
|
|
23
|
Laga AC, Zhan Q, Weishaupt C, Ma J, Frank
MH and Murphy GF: SOX2 and nestin expression in human melanoma: An
immunohistochemical and experimental study. Exp Dermatol.
20:339–345. 2011.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Singh S, Zafar A, Khan S and Naseem I:
Towards therapeutic advances in melanoma management: An overview.
Life Sci. 174:50–58. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Peng WX, Koirala P and Mo YY:
LncRNA-mediated regulation of cell signaling in cancer. Oncogene.
36:5661–5667. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Yu X, Zheng H, Tse G, Chan MT and Wu WK:
Long non-coding RNAs in melanoma. Cell Prolif.
51(e12457)2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Richtig G, Ehall B, Richtig E,
Aigelsreiter A, Gutschner T and Pichler M: Function and clinical
implications of long non-coding RNAs in melanoma. Int J Mol Sci.
18(715)2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Long J, Menggen Q, Wuren Q, Shi Q and Pi
X: Long noncoding RNA taurine-upregulated gene1 (TUG1) promotes
tumor growth and metastasis through
TUG1/Mir-129-5p/astrocyte-elevated gene-1 (AEG-1) axis in malignant
melanoma. Med Sci Monit. 24:1547–1559. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wang Y, Liu G, Ren L, Wang K and Liu A:
Long non-coding RNA TUG1 recruits miR-29c-3p from its target gene
RGS1 to promote proliferation and metastasis of melanoma cells. Int
J Oncol. 54:1317–1326. 2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Thomson DW and Dinger ME: Endogenous
microRNA sponges: Evidence and controversy. Nat Rev Genet.
17:272–283. 2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zhuang S, Liu F and Wu P: Upregulation of
long noncoding RNA TUG1 contributes to the development of
laryngocarcinoma by targeting miR-145-5p/ROCK1 axis. J Cell
Biochem. 120:13392–13402. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Ren K, Li Z, Li Y, Zhang W and Han X: Long
noncoding RNA taurine-upregulated gene 1 promotes cell
proliferation and invasion in gastric cancer via negatively
modulating miRNA-145-5p. Oncol Res. 25:789–798. 2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Shi L, Tian C, Sun L, Cao F and Meng Z:
The lncRNA TUG1/miR-145-5p/FGF10 regulates proliferation and
migration in VSMCs of hypertension. Biochem Biophys Res Commun.
501:688–695. 2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Zeng B, Ye H, Chen J, Cheng D, Cai C, Chen
G, Chen X, Xin H, Tang C and Zeng J: LncRNA TUG1 sponges miR-145 to
promote cancer progression and regulate glutamine metabolism via
Sirt3/GDH axis. Oncotarget. 8:113650–113661. 2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Ozen M, Karatas OF, Gulluoglu S, Bayrak
OF, Sevli S, Guzel E, Ekici ID, Caskurlu T, Solak M, Creighton CJ
and Ittmann M: Overexpression of miR-145-5p inhibits proliferation
of prostate cancer cells and reduces SOX2 expression. Cancer
invest. 33:251–258. 2015.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Tang W, Zhang X, Tan W, Gao J, Pan L, Ye
X, Chen L and Zheng W: miR-145-5p suppresses breast cancer
progression by inhibiting SOX2. J Surg Res. 236:278–287.
2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Zou G, Liu T, Guo L, Huang Y, Feng Y,
Huang Q and Duan T: miR-145 modulates lncRNA-ROR and Sox2
expression to maintain human amniotic epithelial stem cell
pluripotency and β islet-like cell differentiation efficiency.
Gene. 591:48–57. 2016.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Zeng H, Wang L, Wang J, Chen T, Li H,
Zhang K, Chen J, Zhen S, Tuluhong D, Li J and Wang S:
microRNA-129-5p suppresses Adriamycin resistance in breast cancer
by targeting SOX2. Arch Biochem Biophys. 651:52–60. 2018.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Girouard SD, Laga AC, Mihm MC, Scolyer RA,
Thompson JF, Zhan Q, Widlund HR, Lee CW and Murphy GF: SOX2
contributes to melanoma cell invasion. Lab Invest. 92:362–370.
2012.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Fang W, Fan Y, Fa Z, Xu J, Yu H, Li P and
Gu J: microRNA-625 inhibits tumorigenicity by suppressing
proliferation, migration and invasion in malignant melanoma.
Oncotarget. 8:13253–13263. 2017.PubMed/NCBI View Article : Google Scholar
|
